Literature DB >> 32339515

Imperatorin: A review of its pharmacology, toxicity and pharmacokinetics.

Mao Deng1, Long Xie2, Li Zhong3, Yanmei Liao4, Luona Liu5, Xiaofang Li6.   

Abstract

As a naturally occurring furanocoumarin, the medicinal value of imperatorin has been studied more and more. We hope to provide useful information for the further development of imperatorin by analyzing the literature of imperatorin in recent years. By collating the literature on the pharmacology of imperatorin, we found that the pharmacological activity of imperatorin is wide and imperatorin can be used for anti-cancer, neuroprotection, anti-inflammatory, anti-hypertension and antibacterial. In addition, we found that some researchers confirmed the toxicity of imperatorin. Pharmacokinetic studies demonstrated that oxidation metabolism is the main metabolic pathways of imperatorin. At present, the shortcomings of research on imperatorin mainly include: most pharmacological studies are concentrated in vitro, lacking enough in vivo experimental data; more and more studies showed that imperatorin has synergistic effect with other drugs in anticancer and other aspects, but lacking the detailed explanation of the mechanism of the synergistic effect; imperatorin has side effect, but it lacks enough experimental conclusions. Based on the above defects, we believe that more in vivo experiments of imperatorin should be carried out in the future; future research need to explore synergistic mechanisms of imperatorin with other drugs, especially in anticancer; the dose affects both the pharmacological activity and the side effect of imperatorin. The relationship between the dose and the two aspects need to be further studied in order to reduce the side effect. In addition, through structural modification of imperatorin, it is possible to improve the treatment effect and reduce side effect.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Imperatorin; Pharmacokinetics; Pharmacology; Toxicology

Year:  2020        PMID: 32339515     DOI: 10.1016/j.ejphar.2020.173124

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  Network Pharmacology-Based Investigation on Therapeutic Mechanisms of the Angelica dahurica Radix and Ligusticum chuanxiong Rhizoma Herb Pair for Anti-Migraine Effect.

Authors:  Chu Duc Thanh; Chu Van Men; Hyung Min Kim; Jong Seong Kang
Journal:  Plants (Basel)       Date:  2022-08-24

2.  Imperatorin Relieved Ulcerative Colitis by Regulating the Nrf-2/ARE/HO-1 Pathway in Rats.

Authors:  Min Luo; Yin Luo
Journal:  Inflammation       Date:  2020-10-23       Impact factor: 4.092

Review 3.  From Preclinical Stroke Models to Humans: Polyphenols in the Prevention and Treatment of Stroke.

Authors:  Edoardo Parrella; Cristina Gussago; Vanessa Porrini; Marina Benarese; Marina Pizzi
Journal:  Nutrients       Date:  2020-12-29       Impact factor: 5.717

Review 4.  Pharmacological perspectives and molecular mechanisms of coumarin derivatives against virus disease.

Authors:  Zhoupeng Li; Dehui Kong; Yongsheng Liu; Mingkai Li
Journal:  Genes Dis       Date:  2021-04-20

5.  Imperatorin induces autophagy and G0/G1 phase arrest via PTEN-PI3K-AKT-mTOR/p21 signaling pathway in human osteosarcoma cells in vitro and in vivo.

Authors:  Minchao Lv; Qingxin Xu; Bei Zhang; Zhiqiang Yang; Jun Xie; Jinku Guo; Feixiong He; Wei Wang
Journal:  Cancer Cell Int       Date:  2021-12-19       Impact factor: 5.722

Review 6.  The Angelica dahurica: A Review of Traditional Uses, Phytochemistry and Pharmacology.

Authors:  Hui Zhao; Ya-Long Feng; Ming Wang; Jing-Jing Wang; Tian Liu; Jun Yu
Journal:  Front Pharmacol       Date:  2022-07-01       Impact factor: 5.988

7.  Coumarins, furocoumarins and limonoids of Citrus trifoliata and their effects on human colon adenocarcinoma cell lines.

Authors:  Diána Kerekes; Attila Horváth; Norbert Kúsz; Botond Lajos Borcsa; Nikoletta Szemerédi; Gabriella Spengler; Dezső Csupor
Journal:  Heliyon       Date:  2022-08-29

8.  Emodin inhibits viability, proliferation and promotes apoptosis of hypoxic human pulmonary artery smooth muscle cells via targeting miR-244-5p/DEGS1 axis.

Authors:  Li Yi; JunFang Liu; Ming Deng; Huihua Zuo; Mingyan Li
Journal:  BMC Pulm Med       Date:  2021-07-31       Impact factor: 3.317

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.